Update On Oral Lichen Planus: Etiopathogenesis and Management
Open Access
- 1 January 1998
- journal article
- review article
- Published by SAGE Publications in Critical Reviews in Oral Biology & Medicine
- Vol. 9 (1), 86-122
- https://doi.org/10.1177/10454411980090010501
Abstract
Lichen planus (LP) is a relatively common disorder of the stratified squamous epithelia, which is, in many ways, an enigma. This paper is the consensus outcome of a workshop held in Switzerland in 1995, involving a selection of clinicians and scientists with an interest in the condition and its management. The oral (OLP) eruptions usually have a distinct clinical morphology and characteristic distribution, but OLP may also present a confusing array of patterns and forms, and other disorders may clinically simulate OLP. Lesions may affect other mucosae and/or skin. Lichen planus is probably of multifactorial origin, sometimes induced by drugs or dental materials, often idiopathic, and with an immunopathogenesis involving T-cells in particular. The etiopathogenesis appears to be complex, with interactions between and among genetic, environmental, and lifestyle factors, but much has now been clarified about the mechanisms involved, and interesting new associations, such as with liver disease, have emerged. The management of lichen planus is still not totally satisfactory, and there is as yet no definitive treatment, but there have been advances in the control of the condition. There is no curative treatment available; immunomodulation, however, can control the condition. Based on the observed increased risk of malignant development, OLP patients should be offered regular follow-up examination from two to four times annually and asked to report any changes in their lesions and/or symptoms. Follow-up may be particularly important in patients with atrophic/ulcerative/erosive affections of the tongue, the gingiva, or the buccal mucosa. Much more research is required into the genetic and environmental aspects of lichen planus, into the premalignant potential, and into the possible associations with chronic liver, and other, disorders. More clinical studies are required into the possible efficacy of immunomodulatory drugs such as pentoxifylline and thalidomide.Keywords
This publication has 330 references indexed in Scilit:
- Lichen planus, chronic hepatitis C, and interferonHepatology, 1995
- Immunological disorders in C virus chronic active hepatitis: A prospective case-control studyHepatology, 1994
- Lichen planus associated with chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolutionDigestive Diseases and Sciences, 1992
- Anti-GOR and hepatitis C virus in autoimmune liver diseasesThe Lancet, 1992
- Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneityThe Lancet, 1991
- Keratinocytes as initiators of inflammationThe Lancet, 1991
- Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune processThe Lancet, 1990
- Cyclosporin wash for oral lichen planusThe Lancet, 1990
- Treatment of severe lichen planus with cyclosporineJournal of the American Academy of Dermatology, 1990
- Lichen planus pemphigoides: Report of a case with oral lesionsOral Surgery, Oral Medicine, Oral Pathology, 1987